Search Results for: Kamada

Coronavirus vaccine from recovered patients

Posted on March 29, 2020

Israel’s Kamada is developing a treatment against the coronavirus derived from the blood-plasma of patients who have recovered from the disease and are in convalescence. Kamada says that the plasma is likely to contain antibodies that can be the basis … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Rabies treatment approved

Posted on September 3, 2017

Israeli biotech Kamada has received FDA approval for its anti-rabies vaccination in the US. US company Kedrion will be responsible for distributing the new product.  Kamada is already marketing the anti-rabies vaccine in various countries. http://www.globes.co.il/en/article-kamada-receives-fda-approval-for-rabies-treatment-1001202763

Posted in Israel's Medical Achievements | Leave a comment

Another 9 joint US-Israel projects

Posted on July 15, 2016

The Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation approved funding (worth $21.5 million) for nine new projects.  The Israeli companies involved are Cellect Biotechnology, Evogene, File X, Hinoman, IAI, Kamada, Keystone Heart, MedAware and Mellanox. http://www.birdf.com/?CategoryID=427&ArticleID=511

Posted in Economy & Business | Leave a comment

Rabies vaccine is ready for US market

Posted on January 17, 2016

Following successful trials, Israeli biotech Kamada has launched its KamRAB anti-Rabies vaccine in 10 countries, including Israel. Kamada will now apply for a Biologics License Application (BLA) from the US FDA – the last step before offering a remedy for … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Patent for lung disease treatment

Posted on July 27, 2015

Europe, Russia and Australia approved a patent for Israeli biotech Kamada’s nebulizer that delivers its Alpha1-Proteinase Inhibitor–Human (AAT) treatment for lung disease. AAT also treats Type 1 diabetes and immune system diseases. Its USA brand name is Glassia. http://www.marketwatch.com/story/kamada-granted-key-new-patent-for-inhaled-aat-and-eflow-nebulizer-system-in-israel-2015-07-01 http://www.kamada.com/press_item.php?ID=141

Posted in Israel's Medical Achievements | Leave a comment

Canadian patent boosts AAT treatment

Posted on April 19, 2015

Israel’s Kamada has been allowed a patent in Canada for the large-scale production of Alpha-1 Proteinase Inhibitor. The process is key to Kamada’s treatments for alpha-1 antitrypsin (AAT) deficient patients suffering from type-1 diabetes and pulmonary diseases, amongst others. http://www.globes.co.il/en/article-kamada-receives-canadian-patent-1001025127

Posted in Israel's Medical Achievements | Leave a comment

Boost for GVHD treatment

Posted on November 2, 2014

The US FDA has given orphan status to Glassia from Israel’s Kamada, to treat Graft-versus-host-disease (GVHD).  Preliminary studies indicate that Glassia may be able to treat and reduce the severity of GVHD, a key life-threatening complication of stem cell transplantation … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment

Reduced treatment times for Emphysema patients

Posted on May 4, 2014

Using the Alpha-P1 Glassia treatment from Israel’s Kamada, sufferers of inherited emphysema can reduce the weekly time taken for infusions down from 70 minutes to just 15. It greatly improves their quality of life. http://finance.yahoo.com/news/kamada-announces-significantly-improved-infusion-120000356.html

Posted in Israel's Medical Achievements | Leave a comment

Japan trials Israeli tumor treatment

Posted on October 13, 2013

(Thanks to Nevet – Broaderview.com) Japan has bought its first IceSense3 systems from Israel’s IceCure Medical. The systems are already approved in the USA and Europe. Now Kamada Medical Center will use two $50,000 IceSense3 systems to kill breast tumors … Continue reading →

Posted in Economy & Business | Leave a comment

True blue-and-white companies

Posted on January 13, 2013

Eight Israeli companies were awarded the President’s Export Award for 2011. They included Kamada – developers of advanced cystic fibrosis medication. Another, SodaStream was on the verge of bankruptcy in 2007 but in 2011 exported $584 million worth of machines … Continue reading →

Posted in Economy & Business | Leave a comment